Reply to: "Switching vs. add-on strategy in PBC treatment: Lessons from UDCA and bezafibrate experience". Harms MH, van Buuren HR, van der Meer AJ. J Hepatol 2020;72:1211-1212.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harms MH, van Buuren HR, van der Meer AJ. Reply to: "Switching vs. add-on strategy in PBC treatment: Lessons from UDCA and bezafibrate experience". J Hepatol 2020;72:1211-1212.
PMID: 32223918